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Abstract
Background: Both Diabetes and ageing are associated with reduced vascular endothelial function.
The exact relationship between the 2 and any improvements from the insulin sensitizer
rosiglitazone have not been explored.
Methods: Thirty controls and sixteen subjects with type 2 diabetes participated in a series of
experiments to examine the interrelationships between age, diabetes and endothelial cell function.
In subjects with diabetes, the insulin sensitizer rosiglitazone (RSG), a drug also known to improve
vascular function, was administered for 3 months to see how it altered these relationships. Resting
forearm flows (RF) and blood flows after 4 min of vascular occlusion (PF) were measured as an
index of endothelial cell function.
Results: RF, measured by venous occlusion plethysmography, was negatively correlated to both
age and diabetes. Administration of RSG for 3 months was associated with an increase in the blood
flow response to venous occlusion so that it was not significantly different than that of age matched
controls. Total PF in control subjects, compared to subjects with diabetes, averaged 56.58 +/- 12.57
and 13.6 +/- 8.01 cc/100 cc tissue per min respectively, and were significantly different (p < 0.01).
After 3 months on RSG, differences between PF in the two groups were no longer evident.
Conclusion: These studies suggest a different mechanism causing a reduction in vascular reactivity
with aging and diabetes.
Background
Normally, aging results in the natural senescence of mul-
tiple organ systems including the kidney [1], the auto-
nomic nervous system [2], and the heart [3]. While
numerous mechanisms are involved in age related
changes in the body, one important factor contributing to
decreased function is a reduction in nitric oxide produc-
tion (a potent vasodilator) in tissues [4]. In addition,
there is a reduction in beta adrenergic receptor sensitivity
associated with the aging process [5], reducing the ability
of the sympathetic nervous system to respond to stress.
Diabetes, similar to the aging process, can be associated
with autonomic nervous system impairment including
endothelial dysfunction and impairment of autonomic
neurons [6,7]. This reduces function in both the sympa-
thetic [8] and the parasympathetic nervous systems [9]. It
can include loss of parasympathetic peripheral nerves and
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damage to autonomic ganglia, both of which are believed
caused by vascular endothelial function [10,11]. Thus
when the body is placed under stress, almost 30% of all
people with diabetes show autonomic impairment. When
autonomic stressors are combined, such as orthostatic
changes and heat exposure together, nearly all patients
with diabetes showed severe autonomic impairment [7].
The common mechanism for many of these changes with
aging and diabetes is the inability of the blood vessels to
adequately dilate. This leaves a predominant vasoconstric-
tor tone, causing inadequate blood supply to the skin and
various organs of the body [12,13].
Endothelial cell function can be assessed by the change in
blood flow after occlusion of the circulation [14]. Since
the vasodilatation that results from local anoxia is entirely
dependent on endothelial cell function and independent
of the autonomic nervous system, this technique shows
the effect of aging and diabetes only on vascular endothe-
lial cells without the complication of involving other ele-
ments of the nervous system. The relationship between
age, diabetes and vascular reactivity to occlusion should
provide some evidence as to the interrelationships
between these factors. This was one purpose of the present
investigation.
Thiazolidinediones have been shown to increase blood
flow in patients with type 2 diabetes by increasing nitric
oxide production in vascular endothelial cells [28]. Fur-
ther, administration of rosiglitazone, a member of this
family (RSG), has been shown to increase resting forearm
blood flows in both non diabetics and people with diabe-
tes [15]. Thus, in the present investigation, a series of
experiments was accomplished on patients with diabetes
to assess the interrelationships between age, diabetes and
RSG administration for 3 months to see if RSG will
improve either the diabetes or age related loss in vascular
reactivity to occlusion or both.
Methods
Subjects
The subjects with diabetes in this study were 8 men and 8
women, all with type 2 diabetes. The mean age, heights,
BMI (Body Mass Index) and weights are shown in table 1
at the onset of the study. There were 15 on ACE inhibitors,
50% were on a statin, 3 were on beta- blockers and all but
1 were non smokers. Fifty percent were classified as having
coronary artery disease and 50% had microalbuminuria.
Sixty six percent had neuropathies, and 75% had retin-
opathies. Mean baseline values were: HbA1c: 8.8+/-2.4,
Total cholesterol: 213+/-80, LDL: 125+/-80, HDL: 45+/-
18, and Triglyceride: 275+/-274. Blood pressure was
132+/-38 systolic and 82+/-29 diastolic. Fourteen of the
16 were identified with hypertension.
Analysis of 3 month values revealed significantly lower
HbA1c: 7.0 (P < .05) and lower trends in cholesterol and
blood pressure: total cholesterol 206, LDL: 117, HDL:
42.9, and Triglyceride: 280. Blood pressure was 126+/-34
systolic and 72+/-22 diastolic. The reduction in both
systolic and diastolic blood pressure was significant.
All medications were kept constant throughout the study.
The younger volunteers represented a healthier cohort
than the patients with diabetes. None of the subjects had
metabolic syndrome, and none smoked. They had a lower
BMI, weight, and were about 5 years younger than the
subjects with type 2 diabetes. None took any type of med-
ication. Their average resting blood pressure was 121+/-34
systolic and 75+/-28 diastolic. For the control group, the
BMI in the younger subjects (less than 45 years) was
23.2+/-6.1 while the older subjects (>45) averaged 27.9+/
-5.3. Both younger and older groups of controls were all
physically active faculty and staff at Loma Linda Univer-
sity, School of Allied Health.
Measurements
Forearm blood flows – Forearm blood flows were meas-
ured by Whitney strain gauge plethysmography. Whitney
Table 1: demographics of subjects with diabetes
Number Age (years) height(cm) weight(kg) BMI HBA1C
men 8
mean 60.0 185.1 101.8 29.6 9.0
sd 19.9 12.5 24.2 5.7 2.8
women 8
mean 63.8 161.9 83.2 31.1 8.4
sd 11.7 6.3 27.3 7.9 1.5
group mean 16 61.2 178.0 96.1 30.0 8.8
sd 10.2 15.6 26.7 6.3 2.4BMC Endocrine Disorders 2005, 5:4 http://www.biomedcentral.com/1472-6823/5/4
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strain gauge plethysmography is a technique of measuring
limb blood flow by volume plethysmography, a full
description is given elsewhere [14,16].
Procedures
Muscle temperature varies in the forearm between 27 and
42 deg C. This is due to the fact that the forearm is a shell
tissue and temperature varies to help gain or loose heat
from the core of the body [17]. Limb tissue temperature
varies with room temperature, clothing, body fat content,
and the phase of the menstrual cycle [18]. Therefore, a
thin person may have resting arm metabolism less than
20% of that of a person with a high body fat content due
to the high Q10 of the tissues [19]. Therefore, to remove
some of the variability in previous studies, a water bath
was used to elevate all forearm temperatures to that of the
core, 37 deg C. Subjects placed their arms in a bath heated
to core body temperature of 37 deg C with the arm held
dependant and the elbow at an angle of 90 degrees such
that their arms were submerged to the belly of the biceps
muscle. The bath was well stirred. After 15 minutes, rest-
ing arm flows were recorded. A 4 min period of arterial
occlusion was then induced by a cuff under the axilla and
inflated to 200 mmHg was then used. The cuff was then
released and blood flow was measured for another 2 min-
utes. All experiments were repeated on controls and sub-
jects with diabetes prior to administration, after 2 and 4
weeks, and 3 months on RSG. Measurements on the con-
trol subjects were repeated at 1 and 3 months.
Statistical analysis
Statistical analysis involved the calculation of means,
standard deviations, T tests, and analysis of variance
(ANOVA). The level of significance was p < 0.05. All data
in "results" is expressed ± the standard deviation. Regres-
sion lines were calculated by the method of least squares.
Results
The results of the experiments are shown in figures 1, 2, 3.
Figure 1 illustrates the blood flow in the control subjects
and subjects with diabetes prior to administration of RSG
after 4 min of vascular occlusion. Prior to occlusion, the
average blood flow in the control subjects was 2.24 +/-
0.64 cc/100 cc tissue/min. After occlusion, for the control
subjects, blood flow peaked at 26.8 +/- 4.86 cc/100 ml tis-
sue/min for the first flow approximately 3 seconds after
vascular occlusion; 2 minutes post occlusion, the flow was
back to the initial resting flow. In contrast, for the subjects
with diabetes, blood flow at rest was only 1.0 +/- 1.02 cc/
100 ml tissue/min. After 4 minutes of occlusion, the peak
flow only averaged 6.4 +/- 2.82 cc/100 ml tissue/min and
after 1 minute post occlusion, flow was 1.5 +/- 1.42 cc/
100 ml tissue/min. The total blood flow response to
occlusion was significantly less in the subjects with diabe-
tes (p < 0.01). Since the duration and magnitude of the
blood flow response to occlusion were different in the
subjects with diabetes compared to control subjects, a sep-
arate calculation was made, the excess flow. This was
accomplished by calculating the total blood flow above
the normal resting flow observed in the 2 minutes follow-
ing vascular occlusion. For the control subjects, the aver-
age excess flow was 56.58 +/- 12.57 cc/100 ml tissue of
blood whereas for the subjects with diabetes the excess
flow was 13.6 +/- 8.01 cc/100 cc tissue resulting from the
occlusion, the data in the control group was significantly
higher than for the group with diabetes (p < 0.01).
After subjects were placed on 4 mg RSG for 3 months, rest-
ing blood flow increased. Resting flows in subjects with
diabetes, when compared to the control subjects, were sig-
nificantly less prior to administration of RSG (p < 0.01)
and after 2 weeks and 4 weeks this difference was pre-
served (p < 0.05). However, after 3 months, while the rest-
ing flows were still numerically less in the subjects with
diabetes, due to the large variance and small number of
subjects, there was no statistical difference in resting
blood flows between controls and subjects with diabetes
(p > 0.05). The total excess flows increased before and
after 2 weeks, 4 weeks and after 3 month administration
This figure shows the blood flow recorded for 2 minutes fol- lowing the release of an arterial occlusion cuff on the brachial  artery in control subjects (diamonds) and subjects with dia- betes (squares) Figure 1
This figure shows the blood flow recorded for 2 minutes fol-
lowing the release of an arterial occlusion cuff on the brachial 
artery in control subjects (diamonds) and subjects with dia-
betes (squares). Illustrated here are the average results for all 
subjects in each group +/- standard deviation. Flows are 
expressed in cc/100 ml muscle per minute and the time scale 
on the bottom is the flow number. Flows are recorded every 
12 seconds starting at 3 seconds post occlusion.BMC Endocrine Disorders 2005, 5:4 http://www.biomedcentral.com/1472-6823/5/4
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with RSG. Blood flows were 13.06+/-8.01, 19.01 +/-8.00,
35.2+/-13.4 and 42.08 +/-20.08 cc/100 cc tissue. Before
and at 3 months, the flows, when compared to the con-
trols, were significantly less (p < 0.05).
Since aging has a known effect on resting and exercising
blood flow, the data in figure 3 has been plotted in rela-
tionship to age. For the control subjects, for example, as
shown at the top of the figure, there was a linear decrease
in post occlusion flows (as well as resting flows) associ-
ated with aging. The regression line through the data
points in fig 3 showed that for every year a subject aged,
they lost 0.51 cc of blood flow per 100 g tissue per minute
in other words, a loss of approximately 5 cc in post occlu-
sive reactive hyperemia for every 10 years increase in age.
For the subjects with diabetes, prior to taking RSG, there
was also an age related loss in excess flow as shown in the
figure. The slopes of the lines between the non-diabetic
and diabetic subjects prior to taking RSG were not statisti-
cally different from each other (p < 0.01). Thus for sub-
jects with diabetes, there was a similar reduction in post
occlusive hyperemia with aging to a greater extent than in
control subjects. After 2 and 4 weeks on RSG, there was
still the same aging effect on the reduction of post occlu-
sive flow however; difference between the groups was
reduced. After 3 months there was no significant
difference in flows in controls and patients with diabetes
when related to age (p > 0.05).
For the controls, the correlation between age and excess
flow was -0.56, a significant correlation (p < 0.01). With
an R2 of 0.31, 30% of the change in flow after occlusion
could be accounted for by age alone. In the subjects with
diabetes, the correlation between age and flow was 0.71
with an R2 of .49 before RSG. Two weeks after RSG the
correlation was 0.61, after 4 weeks was 0.57. After 3
months it was 0.45. Thus, diabetes seems to potentate age-
ing. Before RSG, 20% more of the variability in flows with
age was observed. After 3 months on RSG, the contribu-
tion of ageing to blood flow was the same.
Discussion
Both aging and diabetes are associated with a loss in func-
tion of the cardiovascular system. One commonly
reported factor in both is a reduction in the ability of the
peripheral vasculature to vasodialate [1,2,20]. Normally,
with the arm at rest, there is always both tonic
vasoconstrictor and vasodilator tone to the vascular
endothelial cells. In the skin, for example, there is a slow
tonic release of norepinephrine, a vasoconstrictor, and
acetylcholine, a vasodilator [21-23]. If there is an increase
in vasoconstrictor activity, then vasoconstriction predom-
inates and if more vasodilator activity is present, then
vasodilatation predominates [24]. Thus, even reflex
changes in blood flow can be modulated up or down by
central sympathetic constrictor or dilator activity [24].
In the present investigation, resting blood flow and the
blood flow after vascular occlusion was reduced with
aging and diabetes. These results agree with that shown by
others [15,25]. At first examination, it would appear that
a similar mechanism might be involved in reducing vas-
cular reactivity with age and diabetes. Certainly, in the
present investigation, older subjects with diabetes had a
greater reduction in resting flows and post ischemic flows
than was seen in younger subjects. A simple loss in the
ability to vasodilate would explain both the reduced post
ischemic flows and the shorter duration of the flows. If
vasodilatation were impaired, then blood flows would be
less after ischemia and, when flows began to return to pre
ischemic levels, the dominant vasoconstriction would
shorten the hyperemia as observed here. But the hypere-
mia was not shortened with age for control subjects, only
subjects with diabetes suggesting different mechanisms
causing the reduction in blood flow between age and
diabetes.
Part of the mechanism for reduced resting and post
ischemic blood flow with both aging and diabetes has
been linked to a reduction of the vascular endothelial cells
ability to produce nitric oxide, a potent vasodilator sub-
stance [4]. This may be due to a defect in nitric oxide syn-
thesis, decreased nitric oxide sensitivity or reduced
availability of l-arginine, the precursor of nitric oxide.
This figure shows the blood flow in the forearm of the sub- jects with diabetes at rest (cc/ 100 ml tissue/minute) before  taking rosiglitazone (pre) and at two weeks (2 w), four weeks  (4 w), and three months (3 m) taking 4 ml per day of  Rosiglitazone Figure 2
This figure shows the blood flow in the forearm of the sub-
jects with diabetes at rest (cc/ 100 ml tissue/minute) before 
taking rosiglitazone (pre) and at two weeks (2 w), four weeks 
(4 w), and three months (3 m) taking 4 ml per day of Rosigli-
tazone. All data is shown with the appropriate standard 
deviation.BMC Endocrine Disorders 2005, 5:4 http://www.biomedcentral.com/1472-6823/5/4
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Nitric oxide is released by vascular endothelial cells in
response to a variety of stimuli including sympathetic
vasodilator nerves [4]. But here is where the similarity
may end.
Data presented here make it unlikely that ageing and dia-
betes effect endothelial function by a similar mechanism.
In the graph in figure 3, the relationship between age and
cardiovascular reactivity (excess flows) was linear. For the
subjects with diabetes, there was no statistical difference
in the slopes but the intercept was very different; 77.78 cc
for the control subjects and 31.01 cc for the subjects with
diabetes. Simply looking at these 2 groups of subjects, it
might be inferred that diabetes potentiated the loss in
endothelial function with age. And yet, after 3 months on
RSG, there was no statistical effect of diabetes alone on
This figure illustrates the excess flow above rest during a two minute period after the release of an occlusion cuff on the bra- chial artery of control subjects and subjects with diabetes Figure 3
This figure illustrates the excess flow above rest during a two minute period after the release of an occlusion cuff on the bra-
chial artery of control subjects and subjects with diabetes. Individual data points are shown on control subjects and subjects 
with diabetes prior to initiation of a three month administration of rosiglitazone (pre rsg) and after 2 weeks (2 w), four weeks 
(4 w), and three months (3 m). Data is plotted in relationship to the age of the subject. The regression lines are calculated by 
the method of least squares. On the control subjects the regression line was flow = -0.518 age + 77.78. Prior to administration 
of rosiglitazone of the subjects with diabetes the regression equation was flow = -0.253 age + 31.01. After two weeks of 
administration of rosiglitazone the regression equation was blood flow = -0.348 age + 41.6. After 4 weeks of rosiglitazone the 
regression equation was blood flow = -0.243 age + 50.27. Finally after 3 months of rosiglitazone was post occlusion flow = -
0.274 age + 64.94BMC Endocrine Disorders 2005, 5:4 http://www.biomedcentral.com/1472-6823/5/4
Page 6 of 7
(page number not for citation purposes)
vascular endothelial function but ageing still had a pro-
nounced effect. If a similar mechanism were involved, i.e.
loss of NO in both, it seems too coincidental that the
curves remained parallel relating age to endothelial func-
tion in subjects with diabetes and after 3 months on RSG;
the data from the diabetic subjects would exactly match
the controls.
It seems more likely that 2 separate mechanisms are
involved. While there is a loss in nitric oxide production
with age, it is not clear if this is the sole culprit in causing
a loss of endothelial function with age. The studies on
rosiglitazone also point to this possibility. Recent studies
show at least 2 other mechanisms associated with ageing.
First, there is a loss in beta-adrenergic receptor sensitivity
with ageing due to structural changes in the receptor mak-
ing it insensitive to catacholamines [5]. Since the response
to occlusion is not mediated by sympathetic nerves, this
probably plays little role here. But in a recent study [26],
data was presented which shows that nitric oxide may not
be the predominant factor in controlling skin circulation
after occlusion. These investigators found that the relative
NO-dependent portion of cutaneous active vasodilatation
accounted for 23% of vasodilatation in young subjects.
Other factors were responsible for most of cutaneous
vasodilatation. Even in older subjects, nitric oxide con-
tributed to only 60% of the vasodilatation. Thus, other
mechanisms were involved and possibly other relaxation
factors altering smooth muscle tone in the vascular beds
[27].
Rosiglitazone is a PPAR gamma ligand that has been
shown to increase skin circulation [15,28,29] by increas-
ing nitric oxide production [28]. The fact that nitric oxide
increases with administration of rosiglitazone and yet the
aging effect on endothelial function was not altered sup-
ports the concept of another mechanism involved here.
The improvement in glucose control could also contribute
to the improvement in endothelial function seen in this
experiment. Finally, the use of Beta blockers in a few of the
subjects and physical activity may have had some effect on
these results. Hypertension, in itself may have caused
endothelial damage here. However, there was no differ-
ence in the group of subjects with beta blockers and the
smokes in their response to RSG. While it is well accepted
that the response to vascular occlusion is a means of
examining endothelial function [30], and that nitric oxide
production is reduced in diabetes [31] and with ageing in
vascular endothelial cells [32], the exact mechanism of the
damage, e.g. nitric oxide, prostaglandins etc can not be
fully elucidated without additional studies. More detailed
studies are needed to understand these mechanisms.
Conclusion
1. Aging is associated with a reduction in both resting
forearm blood flows and post ischemic blood flows.
2. Diabetes further exacerbates the cardiovascular dam-
age, reducing vascular endothelial cell reactivity.
3. Administration of RSG and improvement of glucose
control appear to reverse the damage to vascular endothe-
lial cells associated with diabetes but not aging.
4. The reduction in endothelial cell reactivity to occlu-
sions with aging and diabetes are probably due to differ-
ent mechanism.
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